Literature DB >> 21067447

Treatment of patients with refractory diffuse large B-cell lymphoma or mantle cell lymphoma with alemtuzumab, alone or in combination with cytotoxic chemotherapy.

Jun Ho Yi, Seok Jin Kim, Young Hyeh Ko, Won Seog Kim.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21067447     DOI: 10.3109/10428194.2010.529203

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  2 in total

1.  Stability of alemtuzumab solutions at room temperature.

Authors:  Justin T Goldspiel; Barry R Goldspiel; George J Grimes; Peng Yuan; Gopal Potti
Journal:  Am J Health Syst Pharm       Date:  2013-03-01       Impact factor: 2.637

Review 2.  Immune targeted therapy for diffuse large B cell lymphoma.

Authors:  Yaxin Zheng; Junqi Si; Tian Yuan; Sa Ding; Chen Tian
Journal:  Blood Sci       Date:  2021-10-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.